Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,174 public trials 1,875 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Completed

A Study of LY3023414 in Participants With Advanced Cancer

NCT01655225

Conditions
Adenoma, Advanced Cancer, Breast Diseases, +35 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Peggy and Charles Stephenson Oklahoma Cancer Center Oklahoma City, Oklahoma, United States
  • Penn Presbyterian Medical Center Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Study of Selective BRAF Kinase Inhibitor Dabrafenib Monotherapy Twice Daily and in Combination With Dabrafenib Twice Daily and Trametinib Once Daily in Combination Therapy in Subjects With BRAF V600E Mutation Positive Metastatic (Stage IV) Non-small Cell Lung Cancer.

NCT01336634

Conditions
Bronchial Neoplasms, Cancer, Carcinoma, Bronchogenic, +8 more
Locations
  • Novartis Investigative Site Los Angeles, California, United States
  • Novartis Investigative Site Orange, California, United States
  • Novartis Investigative Site Aurora, Colorado, United States
  • Novartis Investigative Site Tampa, Florida, United States
View all 50 locations
View Trial Details
Completed

Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors

NCT02646748

Conditions
Adenocarcinoma, Breast Cancer, Breast Diseases, +59 more
Locations
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • John Wayne Cancer Institute at Providence Saint John's Health Center Santa Monica, California, United States
  • Georgetown University Medical Center Lombardi CCC Washington D.C., District of Columbia, United States
  • Hematology-Oncology Associates of Treasure Coast Port Saint Lucie, Florida, United States
View all 17 locations
View Trial Details
Completed

A Study of PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)

NCT02900664

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Breast Diseases, +31 more
Locations
  • Sidney Kimmel Comprehensive Cancer Center SC-3 Baltimore, Maryland, United States
  • Dana Farber Cancer Center Boston, Massachusetts, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
View all 23 locations
View Trial Details

Related conditions